This website is best viewed in a browser that supports web standards.

Skip to content or, if you would rather, Skip to navigation.

Listen Live
Donate
MARYVILLE

KXCV-KRNW


News Brief

May 8, 2025 |  By: Associated Press

Mifepristone lawsuit arguing for more restrictions on how and when it is used

The Trump administration has asked a judge to toss out a lawsuit from three Missouri, Kansas, and Idaho, seeking to cut off telehealth access to the abortion medication mifepristone.

Justice Department attorneys this week stayed the legal course charted by the Biden administration, though they didn’t directly weigh in on the underlying issue of access to the drug, which is part of the nation’s most common method of abortion.

Rather, the government argued the states don’t have the legal right, or standing, to sue.

“The states are free to pursue their claims in a district where venue is proper, but the states’ claims before this court must be dismissed or transferred pursuant to the venue statute’s mandatory command,” federal government attorneys wrote.

The lawsuit argues that the Food and Drug Administration should roll back access to mifepristone. They filed their complaint after the Supreme Court preserved access to mifepristone last year. They want the FDA to prohibit telehealth prescriptions for mifepristone, require three in-office visits and restrict the point in a pregnancy when it can be used.